Toward the optimization of stent-based treatment for coronary artery disease

Current Opinion in Drug Discovery and Development

Volumn 13, Issue 2, 2010, Pages 157-158

  Romano, Alfredo ^a   Jensen, Michael Rugaard ^b   McAlpine, Jim ^c  

^a Celgene International   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; ANTIMITOTIC AGENT; ANTITHROMBOCYTIC AGENT; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; TACROLIMUS;

ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; GENE THERAPY; HEART MUSCLE REVASCULARIZATION; HUMAN; RESTENOSIS; REVIEW; STENT THROMBOSIS;

CORONARY ARTERY DISEASE; DRUG CARRIERS; DRUG-ELUTING STENTS; HUMANS; PLATELET AGGREGATION INHIBITORS;

EID: 77749246188     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)